We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at yesterday's price action of all companies in this peer group.
Halozyme Therapeutics (NASDAQ:HALO) ranks first with a gain of 26.99%; Orexigen Therapeutics (NASDAQ:OREX) ranks second with a gain of 2.68%; and Neurocrine Biosciences (NASDAQ:NBIX) ranks third with a gain of 2.19%.
Acorda Therapeutics (NASDAQ:ACOR) follows with a gain of 1.66% and Genomic Health (NASDAQ:GHDX) rounds out the top five with a gain of 1.51%.
Halozyme Therapeutics, Inc. develops and commercializes recombinant human enzymes for the infertility, ophthalmology, and oncology communities. The Company's product portfolio is based on intellectual property covering the family of human enzymes known as hyaluronidases. Halozyme's products offer an alternative to slaughterhouse-derived extracts that carry contamination risks.